Home  »  Companies   »  We Analyzed the Future Direction of Twist Bioscien...

We Analyzed the Future Direction of Twist Bioscience Corporation (TWST), Here is What We Found

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Twist Bioscience Corporation (NASDAQ:TWST) went down by -6.17% from its latest closing price compared to the recent 1-year high of $214.07. The company’s stock price has collected -12.30% of loss in the last five trading sessions. Press Release reported on 01/10/22 that Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference

Is It Worth Investing in Twist Bioscience Corporation (NASDAQ :TWST) Right Now?

Opinions of the stock are interesting as 3 analysts out of 8 who provided ratings for Twist Bioscience Corporation declared the stock was a “buy,” while 1 rated the stock as “overweight,” 3 rated it as “hold,” and 1 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


The average price from analysts is $109.67, which is $51.46 above the current price. TWST currently public float of 46.86M and currently shorts hold a 10.43% ratio of that float. Today, the average trading volume of TWST was 599.72K shares.

TWST’s Market Performance

TWST stocks went down by -12.30% for the week, with a monthly drop of -26.34% and a quarterly performance of -42.92%, while its annual performance rate touched -62.61%. The volatility ratio for the week stands at 9.97% while the volatility levels for the past 30 days are set at 8.95% for Twist Bioscience Corporation. The simple moving average for the period of the last 20 days is -19.71% for TWST stocks with a simple moving average of -42.65% for the last 200 days.

Analysts’ Opinion of TWST

Goldman gave a rating of “Neutral” to TWST, setting the target price at $110 in the report published on June 04th of the previous year.

TWST Trading at -33.74% from the 50-Day Moving Average

After a stumble in the market that brought TWST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.58% of loss for the given period.

Volatility was left at 8.95%, however, over the last 30 days, the volatility rate increased by 9.97%, as shares sank -25.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -50.37% lower at present.

During the last 5 trading sessions, TWST fell by -12.30%, which changed the moving average for the period of 200-days by -42.60% in comparison to the 20-day moving average, which settled at $77.37. In addition, Twist Bioscience Corporation saw -18.63% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at TWST starting from Banyai William, who sale 292 shares at the price of $83.49 back on Jan 04. After this action, Banyai William now owns 265,998 shares of Twist Bioscience Corporation, valued at $24,379 using the latest closing price.

Finn Patrick John, the Chief Commercial Officer of Twist Bioscience Corporation, sale 5,994 shares at $75.62 during a trade that took place back on Dec 29, which means that Finn Patrick John is holding 44,291 shares at $453,266 based on the most recent closing price.

Stock Fundamentals for TWST

Equity return is now at value -24.90, with -21.70 for asset returns.

>> 7 Top Picks for the Post-Pandemic Economy <<

Leave a Comment

Your email address will not be published. Required fields are marked *

Is Teradyne Inc. (TER) a Keeper?

Teradyne Inc. (NASDAQ:TER) went up by 3.99% from its latest closing price compared to the recent 1-year high of $168.91. The company’s stock price has




Download Free eBook For


100% free. stop anytime no spam